跳至主要内容
临床试验/CTRI/2018/05/014018
CTRI/2018/05/014018招募中未知

Role of electrochemotherapy for head and neck and breast cancers in a palliative setting - ECT STUDY

Tata memorial hospital0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1 Patients of either gender aged > 18yrs
  • 2 Head and neck cancer and breast patients with advanced skin involvement not suitable for conventional therapeutic treatments
  • 3 Head and neck and breast cancer patients having recurrent disease where options of surgery, radiation and chemotherapy are exhausted and cannot be used
  • 4 Patient refusing conventional modalities of treatment
  • 5 Patients willing to consent for electrochemotherapy

排除标准

  • 1 Patients with deranged renal functions
  • 2 Patients with severe systemic disease
  • 3 Patients with severe co-morbidity medically unfit to undergo procedure
  • 4 Patients allergic to bleomycin/ cisplatin
  • 5 Patients not willing to consent

研究者

相似试验

进行中(未招募)
1 期
Electrochemotherapy of Head and Neck CancerHead and Neck Cancer.We would like to investigate the possible use of electrochemotherapy in recurrent head and neck cancer. Surgery and radiotherapy, with the possible addition of chemotherapy, cures a large part of patients with head and neck cancer. However, in the event of recurrence curative options may be exchausted and the patient is referred for palliative chemotherapy. It is for this patient group, that we would like to propose electrochemotherapy in a clinicaltrial.MedDRA version: 16.0Level: LLTClassification code 10068476Term: ElectrochemotherapySystem Organ Class: 100000004865
EUCTR2013-002723-42-DKRigshospitalet29
已完成
不适用
Electrochemotherapy in head and neck cancer patientshead and neck cancer1003866610019190
NL-OMON36446Vrije Universiteit Medisch Centrum10
Unknown
2 期
Electrochemotherapy on Head and Neck CancerHead Neck Cancer
NCT02549742Rigshospitalet, Denmark25
招募中
2 期
Electrochemotherapy as a first line treatment in recurrent squamous cell carcinoma of the oral cavity and oropharynx: a randomized controlled trial (ECT-HN)
2025-520735-16-00IRCCS Istituto Nazionale Tumori Fondazione Pascale96
已完成
不适用
EURECA (European research on electrochemotherapy in head and neck cancer) projectRecurrent, metastatic HN cancer or primary cancer in patients with severe co-morbidities and/or which only regular treatment with extensive morbidity is availableCancer
ISRCTN78463063IRCCS Policlinico San Matteo Foundation (Italy)120